The SMA gene therapy candidate OAV101 IT, a version of Zolgensma, can be safely given to previously treated patients, per new ...

Zolgensma is the world’s most expensive drug, with a price tag of more than $2.1 million per one-shot intravenous infusion ... on the market of Biogen’s Spinraza (nusinersen), an antisense ...

Additionally, with the growing demand for chronic disease treatments and the ageing baby boomer population, the infusion market is set for significant growth. According to the market research ...

Hims & Hers Stock Hits Record High on Blood-Testing Lab Acquisition ...